bpc-157 fda approval status 2025 approved panel votes to place popular peptide on compounding list FDA's Overreach on Compounded Peptides – bpc-157 fda warning 2025 december

Typical BPC-157 research protocols run 4 to 8 weeks, commonly using 200-800 mcg per day split into one or two subcutaneous doses, with 250 mcg once or twice daily frequently cited as a starting range

For Laboratory Research Use Only : Designed strictly for controlled research environments and compliant laboratory practice with no therapeutic applications intended

If you plan to use it within a few weeks, refrigerator temperatures of 2 to 8 degrees Celsius are acceptable

Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound

Is BPC-157 a GLP-1 research peptide

Anyone who suspects they have experienced a side effect or adverse reaction from any medicine including products obtained online should report this to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk